• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C1抑制剂与人C1中C1r和C1s亚成分的相互作用。

Interaction of C1-inhibitor with the C1r and C1s subcomponents in human C1.

作者信息

Arlaud G J, Reboul A, Sim R B, Colomb M G

出版信息

Biochim Biophys Acta. 1979 Jan 25;576(1):151-62. doi: 10.1016/0005-2795(79)90494-x.

DOI:10.1016/0005-2795(79)90494-x
PMID:760802
Abstract
  1. Insoluble IgG-ovalbumin aggregates were used to bind and activate C1 from human serum. The bound C1 provided a useful reagent for studying the interaction of C1 subcomponents with C1-inhibitor. 2. C1-inhibitor bound to both subcomponents (C1r and C1s in C1 and formed stable complexes of respective apparent molecular weights 197,000 and 185,000, as determined by sodium dodecyl sulphate-polyacrylamide gel electrophoresis. The binding reaction proceeded more readily with C1s than with C1r and was correlated with the inhibition of C1s esterase activity. 3. At physiological ionic strength, binding of C1-inhibitor to subcomponents C1r and C1s caused release of these subcomponents from the C1-immune aggregates complex, indicating that C1-inhibitor binding decreased the inter-subcomponent binding forces in C1. At low ionic strength, however, this release did not occur.
摘要
  1. 不溶性免疫球蛋白-卵清蛋白聚集体用于结合并激活人血清中的C1。结合的C1为研究C1亚组分与C1抑制物的相互作用提供了一种有用的试剂。2. C1抑制物与C1中的两个亚组分(C1r和C1s)结合,并形成了各自表观分子量为197,000和185,000的稳定复合物,这是通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳测定的。C1抑制物与C1s的结合反应比与C1r的反应更容易进行,并且与C1s酯酶活性的抑制相关。3. 在生理离子强度下,C1抑制物与亚组分C1r和C1s的结合导致这些亚组分从C1免疫聚集体复合物中释放出来,这表明C1抑制物的结合降低了C1中亚组分间的结合力。然而,在低离子强度下,这种释放并未发生。

相似文献

1
Interaction of C1-inhibitor with the C1r and C1s subcomponents in human C1.C1抑制剂与人C1中C1r和C1s亚成分的相互作用。
Biochim Biophys Acta. 1979 Jan 25;576(1):151-62. doi: 10.1016/0005-2795(79)90494-x.
2
Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.C1抑制剂(C1 Inh)与补体第一成分C1的亚成分C1r和C1s的液相相互作用。
Biochem J. 1982 Jan 1;201(1):61-70. doi: 10.1042/bj2010061.
3
C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes.人补体成分C1与免疫复合物结合后依赖C1抑制剂的解离
Biochem J. 1979 Jun 1;179(3):449-57. doi: 10.1042/bj1790449a.
4
Activation of the first component of human complement (C1) by antibody-antigen aggregates.抗体-抗原聚集体激活人类补体的第一成分(C1)。
Biochem J. 1978 Nov 1;175(2):383-90. doi: 10.1042/bj1750383.
5
C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.C1解离。人血清中自发产生一种三聚体复合物,其包含C1灭活剂、活化的C1r和C1s酶原。
J Immunol. 1987 Dec 15;139(12):4145-51.
6
The relationship between the binding ability and the rate of activation of the complement component C1.补体成分C1的结合能力与激活速率之间的关系。
Immunology. 1980 Sep;41(1):179-85.
7
C1 subcomponent complexes: basic and clinical aspects.C1亚成分复合物:基础与临床方面
Behring Inst Mitt. 1993 Dec(93):292-8.
8
Biosynthesis of the first component of complement by human fibroblasts.人成纤维细胞补体第一成分的生物合成。
Biochem J. 1977 Dec 1;167(3):647-60. doi: 10.1042/bj1670647.
9
C1 activation and dissociation in disease.疾病中的C1激活与解离
Immunol Lett. 1987 Feb;14(3):249-53. doi: 10.1016/0165-2478(87)90109-x.
10
A simplified procedure for the purification of C1-inactivator from human plasma. Interaction with complement subcomponents C1r and C1s.一种从人血浆中纯化C1抑制物的简化程序。与补体亚成分C1r和C1s的相互作用。
FEBS Lett. 1977 Jul 1;79(1):45-50. doi: 10.1016/0014-5793(77)80347-5.

引用本文的文献

1
C1QA is an invariant biomarker for tissue macrophages.C1QA是组织巨噬细胞的一种不变生物标志物。
bioRxiv. 2024 Jan 28:2024.01.26.577475. doi: 10.1101/2024.01.26.577475.
2
3D artificial round section micro-vessels to investigate endothelial cells under physiological flow conditions.用于在生理流动条件下研究内皮细胞的 3D 人工圆形截面微脉管。
Sci Rep. 2018 Apr 12;8(1):5898. doi: 10.1038/s41598-018-24273-7.
3
The serine protease domain of MASP-3: enzymatic properties and crystal structure in complex with ecotin.MASP-3 的丝氨酸蛋白酶结构域:酶学性质及其与 ecotin 的复合物晶体结构
PLoS One. 2013 Jul 4;8(7):e67962. doi: 10.1371/journal.pone.0067962. Print 2013.
4
An association study of SERPING1 gene and age-related macular degeneration in a Han Chinese population.汉族人群中SERPING1基因与年龄相关性黄斑变性的关联研究。
Mol Vis. 2010 Jan 10;16:1-6.
5
Mammalian lectins in activation and clearance mechanisms involving the complement system.参与补体系统的激活和清除机制的哺乳动物凝集素。
Springer Semin Immunopathol. 1994;15(4):307-26. doi: 10.1007/BF01837363.
6
C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.C1 灭活剂:其作为可溶性 IgG 聚集体对经典补体途径激活的调节因子的效能。
Immunology. 1983 Jun;49(2):215-22.
7
Domain structure and associated functions of subcomponents C1r and C1s of the first component of human complement.人类补体第一成分的亚组分C1r和C1s的结构域结构及相关功能
Proc Natl Acad Sci U S A. 1985 Jul;82(13):4477-81. doi: 10.1073/pnas.82.13.4477.
8
Molecular modelling of human complement subcomponent C1q and its complex with C1r2C1s2 derived from neutron-scattering curves and hydrodynamic properties.基于中子散射曲线和流体动力学性质的人补体亚成分C1q及其与C1r2C1s2复合物的分子模拟
Biochem J. 1985 May 15;228(1):13-26. doi: 10.1042/bj2280013.
9
Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency.血浆蛋白酶对补体第二成分的裂解:对遗传性C1抑制物缺乏症的影响。
Immunology. 1985 Nov;56(3):561-70.
10
C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes.人补体成分C1与免疫复合物结合后依赖C1抑制剂的解离
Biochem J. 1979 Jun 1;179(3):449-57. doi: 10.1042/bj1790449a.